Related references
Note: Only part of the references are listed.Unexpected Challenges in Treating Multidrug-Resistant Gram-Negative Bacteria: Resistance to Ceftazidime-Avibactam in Archived Isolates of Pseudomonas aeruginosa
Marisa L. Winkler et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2015)
Persistence of Klebsiella pneumoniae ST258 as the predominant clone of carbapenemase-producing Enterobacteriaceae in post-acute-care hospitals in Israel, 2008-13
Amos Adler et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2015)
Surveillance of Carbapenem-Resistant Klebsiella pneumoniae: Tracking Molecular Epidemiology and Outcomes through a Regional Network
David van Duin et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
In Vitro Activity of Plazomicin against 5,015 Gram-Negative and Gram- Positive Clinical Isolates Obtained from Patients in Canadian Hospitals as Part of the CANWARD Study, 2011-2012
A. Walkty et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2014)
Tigecycline therapy for carbapenem-resistant Klebsiella pneumoniae (CRKP) bacteriuria leads to tigecycline resistance
D. van Duin et al.
CLINICAL MICROBIOLOGY AND INFECTION (2014)
Ceftazidime/avibactam activity tested against Gram-negative bacteria isolated from bloodstream, pneumonia, intra-abdominal and urinary tract infections in US medical centres (2012)
Robert K. Flamm et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2014)
Nested Case-Control Study of the Emergence of Tigecycline Resistance in Multidrug-Resistant Klebsiella pneumoniae
Masayuki Nigo et al.
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY (2013)
Carbapenem-resistant Enterobacteriaceae: A menace to our most vulnerable patients
Federico Perez et al.
CLEVELAND CLINIC JOURNAL OF MEDICINE (2013)
Carbapenem-resistant Enterobacteriaceae: a review of treatment and outcomes
David van Duin et al.
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE (2013)
Clinical epidemiology of the global expansion of Klebsiella pneumoniae carbapenemases
L. Silvia Munoz-Price et al.
LANCET INFECTIOUS DISEASES (2013)
Prolonged Antibiotic Treatment in Long-term Care Role of the Prescriber
Nick Daneman et al.
JAMA INTERNAL MEDICINE (2013)
The burden of multidrug-resistant organisms on tertiary hospitals posed by patients with recent stays in long-term acute care facilities
Dror Marchaim et al.
AMERICAN JOURNAL OF INFECTION CONTROL (2012)
Predictors of Mortality in Bloodstream Infections Caused by Klebsiella pneumoniae Carbapenemase-Producing K. pneumoniae: Importance of Combination Therapy
Mario Tumbarello et al.
CLINICAL INFECTIOUS DISEASES (2012)
Transfer from High-Acuity Long-Term Care Facilities Is Associated with Carriage of Klebsiella pneumoniae Carbapenemase-Producing Enterobacteriaceae: A Multihospital Study
Kavitha Prabaker et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2012)
Association between Vancomycin-Resistant Enterococci Bacteremia and Ceftriaxone Usage
James A. McKinnell et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2012)
Antibiotic use in long-term care facilities
Nick Daneman et al.
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY (2011)
Potential Role of Active Surveillance in the Control of a Hospital-Wide Outbreak of Carbapenem-Resistant Klebsiella pneumoniae Infection
Debby Ben-David et al.
INFECTION CONTROL AND HOSPITAL EPIDEMIOLOGY (2010)
Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults
Lionel A. Mandell et al.
CLINICAL INFECTIOUS DISEASES (2007)
Guidelines for the management, of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia
[Anonymous]
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2005)
The commonality of risk factors for nosocomial colonization and infection with antimicrobial-resistant Staphylococcus aureus, enterococcus, gram-negative bacilli, Clostridium difficile, and Candida
N Safdar et al.
ANNALS OF INTERNAL MEDICINE (2002)
Share Paper
